Abstract
Breast imaging is an essential component of breast cancer diagnosis and guides surgery and treatment options. Imaging techniques such as mammography, ultrasound (US), and magnetic resonance imaging (MRI) enable the detection of breast cancer at earlier stages. Mammography remains the standard screening examination; however, additional imaging studies are useful in evaluating the breast. US is utilized primarily in the diagnostic setting to characterize mammographic or palpable findings and assess axillary lymph nodes. Supplemental screening US may also be useful in patients with intermediate risk for developing breast cancer and dense breasts to increase cancer detection. In addition to mammography, high-risk patients may also have annual MRI or screening US if they are unable to undergo MRI. MRI is also performed to evaluate the extent of disease, the response to neoadjuvant chemotherapy, and silicone implant integrity. In addition, these imaging modalities are also used to guide percutaneous biopsy, enabling minimally invasive tissue diagnosis. There is insufficient evidence to support the screening use of investigational imaging modalities, such as nuclear medicine breast imaging, and positron emission mammography. However, these topics are briefly discussed for completeness.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tabár L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260(3):658–63.
Coldman A, Phillips N, Warren L, Kan L. Breast cancer mortality after screening mammography in British Columbia women. Int J Cancer. 2007;120(5):1076–80.
ACR practice guidelines for the performance of screening and diagnostic mammography. Amended 2014 (Resolution 39). www.acr.org.
Sickles EA, D’Orsi CJ, Bassett LW. ACR BI-RADS® mammography. In: ACR BI-RADS® Atlas, breast imaging reporting and data system. Reston: American College of Radiology; 2013.
Rosenberg RD, Yankaskas BC, Abraham LA, Sickles DA, Lehman CD, Geller BM, et al. Performance benchmarks for screening mammography. Radiology. 2006;241(1):55–66.
Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Fajardo LL, Bassett L, D’Orsi C, Jong R, Rebner M, Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353(17):1773–83.
Hendrick RE, Pisano ED, Averbukh A, Moran C, Berns EA, Yaffe MJ, et al. Comparison of acquisition parameters and breast dose in digital mammography and screen-film mammography in the American College of Radiology Imaging Network digital mammographic imaging screening trial. AJR Am J Roentgenol. 2010;194(2):362–9.
Hendrick RE. Radiation doses and cancer risks from breast imaging studies. Radiology. 2010;257(1):246–53.
Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92(13):1081–7.
Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356(3):227–36.
Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, et al. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev. 2003;12:332–8.
Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst. 1995;87:670–5.
Harvey JA, Bovbjerg VE. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology. 2004;230:29–41.
McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:11159–69.
Sala E, Warren R, McCann J, Duffy S, Day N, Luben R. Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme. J Med Screen. 1998;5:207–12.
Van Gils CH, Otten JD, Verbeek AL, Hendriks JH. Mammographic breast density and risk of breast cancer: masking bias or causality? Eur J Epidemiol. 1998;14:315–20.
Berg WA. Special topics. In: Berg WB, Yang WT, editors. Diagnostic imaging breast, vol. 8. 2nd ed. Manitoba: Amyrsis; 2014. p. 98–100.
Dialani V, Baum J, Mehta TS. Sonographic features of gynecomastia. J Ultrasound Med. 2010;29(4):539–47.
Günhan-Bilgen I, Bozkaya H, Ustün E, Memiş A. Male breast disease: clinical, mammographic, and ultrasonographic features. Eur J Radiol. 2002;43(3):246–55.
Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955–1996. Cancer. 1996;85(3):629–39.
Symmers WS. Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. Br Med J. 1968;2(5597):83–5.
Chantra PK, So GJ, Wollman JS, Bassett LW. Mammography of the male breast. AJR Am J Roentgenol. 1995;164(4):853–8.
Shi AA, Georgian-Smith D, Cornell LD, Rafferty EA, Staffa M, Hughes K, et al. Radiological reasoning: male breast mass with calcifications. AJR Am J Roentgenol. 2005;185(6 Suppl):S205–10.
Chen L, Chantra PK, Larsen LH, Barton P, Rohitopakarn M, Zhu EQ, et al. Imaging characteristics of malignant lesions of the male breast. Radiographics. 2006;26(4):993–1006.
Adibelli ZH, Oztekin O, Gunhan-Bilgen I, Postaci H, Uslu A, Ilhan E. Imaging characteristics of male breast disease. Breast J. 2010;16(5):510–8.
Breast Cancer Screening and Diagnosis. NCCN Guidelines Version 1. 2015. www.nccn.org.
Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 2010;7(1):18–27.
American Cancer Society. Detailed guide: breast cancer. Accessed at http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/index on 4 Feb 2013.
Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, König R, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol. 2010;28(9):1450–7.
Kuhl C. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology. 2007;244(2):356–78.
Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG, ACRIN 6666 Investigators, et al. Detection of breast cancer with addition of annual screening ultrasound or a singles screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394–404.
Berg WA. Screening and management. In: Berg WA, Yang WT, editors. Diagnostic imaging breast. 2nd ed. Manitoba: Amirsys; 2014, 9:45.
Loving VA, DeMartini WB, Eby PR, Gutierrez RL, Peacock S, Lehman CD. Targeted ultrasound in women younger than 30 years with focal breast signs or symptoms: outcomes analyses and management implications. Am J Roentgenol. 2010;195:1472–7.
Harper AP, Kelly-Fry E, Noe JS, Bies JR, Jackson VP. Ultrasound in the evaluation of solid breast masses. Radiology. 1983;146(3):731–6.
Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Böhm-Vélez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299(18):2151–63.
Berg WA. Screening and management. In: Berg WA, Yang WT, editors. Diagnostic imaging breast. 2nd ed. Manitoba: Amirsys; 2014, 9:38.
Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09–41. Radiology. 2012;265(1):59–69.
Berg WA. Screening and management. In: Berg WA, Yang WT, editors. Diagnostic imaging breast. 2nd ed. Manitoba: Amirsys; 2014, 9:44, 46.
Yamada T, Mori N, Watanabe M, Kimijima I, Okumoto T, Seiji K, et al. Radiologic-pathologic correlation of ductal carcinoma in situ. Radiographics. 2010;30(5):1183–98.
Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology. 2006;238(1):42–53.
Kuhl CK, Schrading S, Bieling HB, Wardelmann E, Leutner CC, Koenig R, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370(9586):485–92.
Bluemke DA, Gatsonis CA, Chen MH, DeAngelis GA, DeBruhl N, Harms S, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA. 2004;292:2735–42.
American College of Radiology practice guideline for the performance of contrast-enhanced Magnetic Resonance Imaging (MRI) of the breast: 2013 http://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/MRI_Breast.pdf. Accessed 20 Nov 2013.
de Bresser J, de Vos B, van der Ent F, Hulsewé K. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. Eur J Surg Oncol. 2010;36(2):114–9.
Olson Jr JA, Morris EA, Van Zee KJ, Linehan DC, Borgen PI. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol. 2000;7:411–5.
Abe H, Schmidt RA, Shah RN, Shimauchi A, Kulkarni K, Sennett CA, et al. MRI-directed (“Second-Look”) ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. Am J Roentgenol. 2010;194(2):370–7.
Meissnitzer M, Dershaw DD, Lee CH, Morris EA. Targeted ultrasound of the breast in women with abnormal MRI findings for whom biopsy has been recommended. Am J Roentgenol. 2009;193(4):1025–9.
Lehman CD, Gastonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295–303.
Boetes C, Mus RD, Holland R, Barentsz JO, Strijk SP, Wobbes T, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology. 1995;197:743–7.
Orel SG, Schnall MD, Powell CM, Hochman MG, Solin LJ, Fowble BL, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology. 1995;196:115–22.
Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK. MR Imaging of the ipsilateral breast in women with percutaneously proven breast cancer. Am J Roentgenol. 2003;180:901–10.
Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830–49.
Houssami N, Turner R, Macaskill P, Turnbull LW, McCready DR, Tuttle T, et al. An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence. J Clin Oncol. 2014;32(5):392–401.
Fischer U, Zachariae O, Baum F, von Heyden D, Funke M, Liersch T. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol. 2004;14(10):1725–31.
Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomized controlled trial. Lancet. 2010;375(9714):563–71.
Hakim CM, Ganott MA, Vogia A, Sumkin JH. Breast imaging for pathologists. In: Dabbs DJ, editor. Breast pathology. Philadelphia: Saunders (Elsevier); 2012. p. 133.
Rosen EL, Blackwell KL, Baker JA, Soo MS, Bentley RC, Yu D, et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol. 2003;181(5):1275–82.
Yeh E, Slanetz P, Kopans DB, Rafferty E, Georgian-Smith D, Moy L, et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol. 2005;184(3):868–77.
Lobbes MB, Prevos R, Smidt M, Tjan-Heijnen VC, van Goethem M, Schipper R, et al. The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review. Insights Imaging. 2013;4(2):163–75.
Lee JM, Orel SG, Czerniecki BJ, Solin LJ, Schnall MD. MRI before re excision surgery in patients with breast cancer. AJR Am J Roentgenol. 2004;182:473–80.
ACR Committee on Drugs and Contrast Media. Chapter 13: Nephrogenic systemic fibrosis. ACR Manual on Contrast Media. Version 9. 2013. pp 81–9. http://geiselmed.dartmouth.edu/radiology/pdf/ACR_manual.pdf.
Haas BM, Kalra V, Geisel J, Raghu M, Durand M, Philpotts LE. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology. 2013;269(3):694–700.
Skaane P, Bandos AI, Gullien R, Eben EB, Ekseth U, Haakenaasen U, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population based screening program. Radiology. 2013;267:47–56.
Vreugdenburg TD, Willis CD, Mundy L, Hiller JE. A systematic review of elastography, electrical impedance scanning, and digital infrared thermography for breast cancer screening and diagnosis. Breast Cancer Res Treat. 2013;137(3):665–76.
Berg WA, Cosgrove DO, Doré CJ, Schäfer FK, Svensson WE, Hooley RJ, et al. Shear-wave elastography improves the specificity of breast US: the BE1 multinational study of 939 masses. Radiology. 2012;262(2):435–49.
Sun Y, Wei W, Yang HW, Liu JL. Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2013;40(3):450–63.
Conners AL, Maxwell RW, Tortorelli CL, Hruska CB, Rhodes DJ, Boughey JC, et al. Gamma camera breast imaging lexicon. AJR Am J Roentgenol. 2012;199(6):W767–74.
Glass SB, Shah ZA. Clinical Utility of positron emission mammography. Proc (Bayl Univ Med Cent). 2013;26(3):314–9.
Narayanan D, Madsen KS, Kalinyak JE, Berg WA. Interpretation of positron emission mammography: feature analysis and rates of malignancy. AJR Am J Roentgenol. 2011;196(4):956–70.
Caldarella C, Treglia G, Giordano A. Diagnostic performance of dedicated positron emission mammography using flourin-18-fluorodeoxyglucose in women with suspicioud breast lesions: a meta-analysis. Clin Breast Cancer. 2014;14(4):241–8.
Berg WA, Madsen KS, Schilling K, Tartar M, Pisano ED, Hovanessian Larsen L, et al. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer. AJR Am J Roentgenol. 2012;198:219–32.
Berg WA, Madsen KS, Schilling K, Tartar M, Pisano ED, Hovanessian Larsen L, et al. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology. 2011;258(1):59–72.
Pisano ED, Fajardo LL, Caudry DJ, Sneige N, Frable WJ, Berg WA, et al. Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group V. Radiology. 2001;219(3):785–92.
Pisano ED, Fajardo LL, Tsimikas J, Sneige N, Frable WJ, Gatsonis CA, et al. Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: the Radiologic Diagnostic Oncology Group 5 Study. The RDOG5 investigators. Cancer. 1998;82(4):679–88.
Berg WA. Image-guided breast biopsy and management of high-risk lesions. Radiol Clin North Am. 2004;42(5):935–46.
Youk JH, Kim EK, Kim MJ, Oh KK. Sonographically guided 14-gauge core needle biopsy of breast masses: a review of 2,420 cases with long-term follow-up. AJR Am J Roentgenol. 2008;190(1):202–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ganott, M., Griffith, B., Rudzinski, S.M. (2016). Breast Imaging and Image-Guided Biopsy Techniques. In: Aydiner, A., İğci, A., Soran, A. (eds) Breast Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-22843-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-22843-3_5
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22842-6
Online ISBN: 978-3-319-22843-3
eBook Packages: MedicineMedicine (R0)